News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
412,586 Results
Type
Article (27727)
Company Profile (115)
Press Release (384740)
Multimedia
Podcasts (66)
Webinars (12)
Section
Business (102266)
Career Advice (545)
Deals (18043)
Drug Delivery (91)
Drug Development (38944)
Employer Resources (80)
FDA (10905)
Job Trends (10026)
News (176066)
Policy (20867)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (2122)
Academic (2)
Accelerated approval (21)
Adcomms (16)
Allergies (94)
Alliances (28680)
ALS (88)
Alzheimer's disease (1112)
Antibody-drug conjugate (ADC) (149)
Approvals (11216)
Artificial intelligence (365)
Autoimmune disease (84)
Automation (20)
Bankruptcy (148)
Best Places to Work (9003)
BIOSECURE Act (8)
Biosimilars (157)
Biotechnology (58)
Bladder cancer (103)
Brain cancer (35)
Breast cancer (358)
Cancer (2552)
Cardiovascular disease (289)
Career advice (508)
Career pathing (14)
CAR-T (117)
CDC (51)
Cell therapy (366)
Cervical cancer (26)
Clinical research (34109)
Collaboration (1066)
Compensation (148)
Complete response letters (22)
COVID-19 (2305)
CRISPR (52)
C-suite (508)
Cystic fibrosis (88)
Data (3763)
Decentralized trials (2)
Denatured (21)
Depression (108)
Diabetes (342)
Diagnostics (5165)
Digital health (46)
Diversity (10)
Diversity, equity & inclusion (24)
Drug discovery (140)
Drug pricing (169)
Drug shortages (12)
Duchenne muscular dystrophy (127)
Earnings (36251)
Editorial (40)
Employer branding (8)
Employer resources (73)
Events (76255)
Executive appointments (662)
FDA (13077)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (5)
Frontotemporal dementia (15)
Funding (1040)
Gene editing (99)
Generative AI (34)
Gene therapy (288)
GLP-1 (593)
Government (4391)
Grass and pollen (6)
Guidances (284)
Healthcare (15090)
HIV (54)
Huntington's disease (18)
IgA nephropathy (49)
Immunology and inflammation (113)
Immuno-oncology (29)
Indications (73)
Infectious disease (2550)
Inflammatory bowel disease (124)
Inflation Reduction Act (16)
Influenza (110)
Intellectual property (114)
Interviews (59)
IPO (7786)
IRA (40)
Job creations (1411)
Job search strategy (450)
JPM (61)
Kidney cancer (4)
Labor market (39)
Layoffs (212)
Leadership (11)
Legal (3939)
Liver cancer (57)
Longevity (12)
Lung cancer (314)
Lymphoma (203)
Machine learning (20)
Management (30)
Manufacturing (410)
MASH (106)
Medical device (9629)
Medtech (9673)
Mergers & acquisitions (10939)
Metabolic disorders (852)
Multiple sclerosis (113)
NASH (10)
Neurodegenerative disease (186)
Neuropsychiatric disorders (61)
Neuroscience (1891)
Neurotech (1)
NextGen: Class of 2026 (4993)
Non-profit (3949)
Now hiring (13)
Obesity (393)
Opinion (159)
Ovarian cancer (80)
Pain (111)
Pancreatic cancer (90)
Parkinson's disease (158)
Partnered (21)
Patents (220)
Patient recruitment (282)
Peanut (32)
People (33692)
Pharmaceutical (31)
Pharmacy benefit managers (29)
Phase 1 (10802)
Phase 2 (13402)
Phase 3 (12130)
Pipeline (3385)
Policy (242)
Postmarket research (1574)
Preclinical (3463)
Press Release (47)
Prostate cancer (145)
Psychedelics (38)
Radiopharmaceuticals (170)
Rare diseases (538)
Real estate (2876)
Recruiting (33)
Regulatory (15607)
Reports (25)
Research institute (1967)
Resumes & cover letters (40)
Rett syndrome (20)
RNA editing (6)
RSV (65)
Schizophrenia (108)
Series A (162)
Series B (135)
Service/supplier (4)
Sickle cell disease (73)
Special edition (11)
Spinal muscular atrophy (95)
Sponsored (28)
Startups (2115)
Stomach cancer (4)
Supply chain (71)
Tariffs (47)
The Weekly (44)
Vaccines (853)
Venture capital (68)
Weight loss (239)
Women's health (84)
Worklife (7)
Date
Today (70)
Last 7 days (357)
Last 30 days (1371)
Last 365 days (18729)
2026 (2051)
2025 (19045)
2024 (21774)
2023 (24261)
2022 (33690)
2021 (37126)
2020 (37571)
2019 (33252)
2018 (24877)
2017 (17708)
2016 (18859)
2015 (21430)
2014 (16060)
2013 (12721)
2012 (13464)
2011 (13905)
2010 (11929)
Location
Africa (531)
Alabama (35)
Alaska (6)
Arizona (186)
Arkansas (11)
Asia (22435)
Australia (3970)
California (6224)
Canada (2185)
China (615)
Colorado (308)
Connecticut (335)
Delaware (192)
Europe (50451)
Florida (992)
Georgia (262)
Hawaii (2)
Idaho (39)
Illinois (601)
India (56)
Indiana (453)
Iowa (13)
Japan (298)
Kansas (89)
Kentucky (27)
Louisiana (24)
Maine (79)
Maryland (951)
Massachusetts (4606)
Michigan (220)
Minnesota (401)
Mississippi (3)
Missouri (121)
Montana (18)
Nebraska (20)
Nevada (93)
New Hampshire (59)
New Jersey (2168)
New Mexico (12)
New York (1955)
North Carolina (969)
North Dakota (4)
Northern California (3113)
Ohio (219)
Oklahoma (13)
Oregon (28)
Pennsylvania (1439)
Puerto Rico (12)
Rhode Island (29)
South America (681)
South Carolina (34)
South Dakota (1)
Southern California (2356)
Tennessee (139)
Texas (947)
United States (24579)
Utah (265)
Virginia (144)
Washington D.C. (53)
Washington State (603)
West Virginia (3)
Wisconsin (89)
Wyoming (2)
412,586 Results for "guardant health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Guardant Health to Participate in Upcoming Investor Conferences - February 3, 2026
February 4, 2026
·
1 min read
Press Releases
Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform
January 19, 2026
·
3 min read
Press Releases
Guardant Health Receives FDA Approval for Guardant360® CDx as Companion Diagnostic for BRAFTOVI® (encorafenib) Combination in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
January 23, 2026
·
5 min read
Press Releases
Guardant Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
January 30, 2026
·
1 min read
Press Releases
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results
January 12, 2026
·
5 min read
Press Releases
Guardant Health Announces Proposed Public Offering of Common Stock
November 4, 2025
·
6 min read
Press Releases
Guardant Health to Participate in Upcoming Investor Conferences - November 7, 2025
November 10, 2025
·
1 min read
Press Releases
Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S.
December 12, 2025
·
5 min read
Press Releases
Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant’s Shield™ Blood-based Screening Test in the United States
September 25, 2025
·
6 min read
Press Releases
Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
October 29, 2025
·
17 min read
1 of 41,259
Next
